Table 2.

Multivariate Cox regression analysis of PGS in SU2C and Alumkal clinical cohorts.

Cohort	Covariates	Coefficients	SE	P	HR (95% CI)
SU2C	Age (<65 vs. ≥65 y/o)	0.791	0.41	0.054	2.205 (0.987–4.923)
	Gleason score (<7 vs. ≥7)	0.581	0.421	0.168	1.787 (0.783–4.078)
	PSA at diagnosis (<20 vs. ≥20 μg/mL)	0.001	0.001	0.095	1.001 (1.000–1.002)
	PGS (PGS = 1 vs. PGS = 0)	1.326	0.449	0.003	3.767 (1.561–9.088)
Alumkal	Age (<65 vs. ≥65 y/o)	0.994	0.706	0.159	2.702 (0.678–10.772)
	Gleason score (<7 vs. ≥7)	0.339	0.522	0.516	1.404 (0.505–3.905)
	PSA at diagnosis (<20 vs. ≥20 μg/mL)	0.557	0.596	0.350	1.746 (0.543–5.613)
	PGS (PGS = 1 vs. PGS = 0)	1.741	0.61	0.004	5.702 (1.726–18.842)